Literature DB >> 2442693

Species-specific and common epitopes on the secreted and surface antigens of Toxocara cati and Toxocara canis infective larvae.

M W Kennedy, R M Maizels, M Meghji, L Young, F Qureshi, H V Smith.   

Abstract

It is widely accepted that the major cause of visceral larva migrans (VLM) in man is Toxocara canis infection. This has been largely based on the detection of antibodies to this species. We have compared the antigens of T. canis and Toxocara cati in order to establish whether assay for the former might be compromised by infection with the latter. Comparisons were made by radioiodination of the surface and excretory/secretory (ES) glycoproteins of the infective larvae of both species, immunoprecipitation with poly- and monoclonal reagents, and SDS-PAGE. The SDS-PAGE profiles of surface antigens of the two species showed few similarities, whereas that of the ES material indicated considerable homology. Serum from infected animals and a human VLM patient exhibited complete cross reactivity, although there was evidence in the mouse of a specific response to one of the components of T. cati ES. Testing of ES against a panel of monoclonal antibodies (MoAbs) confirmed the similarity; all but one of the MoAbs recognized several of the components of both sources of ES. The only exception was MoAb Tcn-2, which did not react with T. cati surface, somatic or ES antigens. This antibody is known to recognize a carbohydrate determinant which is widespread on T. canis glycoproteins. This species-specific determinant, therefore, represents a reversal of the consensus that peptide determinants tend to be the more specific. Finally, the MoAbs were used to examine the exposure of shared epitopes on the surface of intact larvae of T. cati. Again, fine differences in binding by anti-carbohydrate monoclonals were observed when the two species of Toxocara were compared, reflecting a distinction in exposure or orientation of surface molecules on these nematodes. Moreover, these epitopes were absent or variably present on the surface of freshly hatched larvae, and full exposure did not occur until about 24 h post-hatching. This delay in the presentation of epitopes might have implications for the process of infection in sensitized hosts. In conclusion, it is probable that the serological response in man to T. canis is, by current serological methods, indistinguishable in specificity from that induced by T. cati infection, and that the MoAb which we describe could be used to permit discrimination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442693     DOI: 10.1111/j.1365-3024.1987.tb00519.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  14 in total

1.  Evaluation of Toxocara cati Excretory-Secretory Larval Antigens in Serodiagnosis of Human Toxocariasis.

Authors:  Mohammad Zibaei; Seyed Mahmoud Sadjjadi; Bahador Sarkari; Shoji Uga
Journal:  J Clin Lab Anal       Date:  2015-04-01       Impact factor: 2.352

2.  Production of Toxocara cati TES-120 Recombinant Antigen and Comparison with its T. canis Homolog for Serodiagnosis of Toxocariasis.

Authors:  Farzaneh Zahabiun; Seyed Mahmoud Sadjjadi; Muhammad Hafiznur Yunus; Anizah Rahumatullah; Mohammad Hosein Falaki Moghaddam; Syazwan Saidin; Rahmah Noordin
Journal:  Am J Trop Med Hyg       Date:  2015-06-01       Impact factor: 2.345

3.  Detection of circulating parasite antigen and specific antibody in Toxocara canis infections.

Authors:  B D Robertson; T R Burkot; S H Gillespie; M W Kennedy; Z Wambai; R M Maizels
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

4.  Antigenic relationships between the surface-exposed, secreted and somatic materials of the nematode parasites Ascaris lumbricoides, Ascaris suum, and Toxocara canis.

Authors:  M W Kennedy; F Qureshi; E M Fraser; M R Haswell-Elkins; D B Elkins; H V Smith
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Characterization of a Toxocara canis species-specific excretory-secretory antigen (TcES-57) and development of a double sandwich ELISA for diagnosis of visceral larva migrans.

Authors:  R D Iddawela; R P V J Rajapakse; N A N D Perera; Takeshi Agatsuma
Journal:  Korean J Parasitol       Date:  2007-03       Impact factor: 1.341

6.  Diagnosis of human toxocariasis by antigen capture enzyme linked immunosorbent assay.

Authors:  S H Gillespie; D Bidwell; A Voller; B D Robertson; R M Maizels
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

7.  Application of the western blotting procedure for the immunodiagnosis of human toxocariasis.

Authors:  J F Magnaval; R Fabre; P Maurières; J P Charlet; B de Larrard
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

8.  Epidemiology and control of child toxocariasis in the western Brazilian Amazon - a population-based study.

Authors:  Humberto Oliart-Guzmán; Breno M Delfino; Antonio C Martins; Saulo A S Mantovani; Athos M Braña; Thasciany M Pereira; Fernando L C C Branco; Alanderson A Ramalho; Rhanderson G Campos; Pablo S Fontoura; Thiago S de Araujo; Cristieli S M de Oliveira; Pascoal T Muniz; Guita Rubinsky-Elefant; Cláudia T Codeço; Mônica da Silva-Nunes
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

9.  In vitro culture of Parascaris equorum larvae and initial investigation of parasite excretory-secretory products.

Authors:  Steffanie V Burk; Sriveny Dangoudoubiyam; Tammy Brewster-Barnes; Uneeda K Bryant; Daniel K Howe; Craig N Carter; Eric S Vanzant; Robert J Harmon; Kevin R Kazacos; Mary G Rossano
Journal:  Parasitol Res       Date:  2014-09-11       Impact factor: 2.289

10.  Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American.

Authors:  Lívia Ribeiro Mendonça; Rafael Valente Veiga; Vitor Camilo Cavalcante Dattoli; Camila Alexandrina Figueiredo; Rosemeire Fiaccone; Jackson Santos; Álvaro Augusto Cruz; Laura Cunha Rodrigues; Philip John Cooper; Lain Carlos Pontes-de-Carvalho; Maurício Lima Barreto; Neuza Maria Alcantara-Neves
Journal:  PLoS Negl Trop Dis       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.